Home Cart 0 Sign in  
X

[ CAS No. 75680-92-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 75680-92-1
Chemical Structure| 75680-92-1
Chemical Structure| 75680-92-1
Structure of 75680-92-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 75680-92-1 ]

Related Doc. of [ 75680-92-1 ]

Alternatived Products of [ 75680-92-1 ]

Product Details of [ 75680-92-1 ]

CAS No. :75680-92-1 MDL No. :MFCD09908168
Formula : C7H7ClN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :GVSVPKDEHFOXSW-UHFFFAOYSA-N
M.W : 186.60 Pubchem ID :10352425
Synonyms :

Calculated chemistry of [ 75680-92-1 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.13
TPSA : 52.08 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.35 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.9
Log Po/w (XLOGP3) : 0.12
Log Po/w (WLOGP) : 1.31
Log Po/w (MLOGP) : 0.89
Log Po/w (SILICOS-IT) : 1.68
Consensus Log Po/w : 1.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.24
Solubility : 10.6 mg/ml ; 0.057 mol/l
Class : Very soluble
Log S (Ali) : -0.77
Solubility : 31.7 mg/ml ; 0.17 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.75
Solubility : 0.331 mg/ml ; 0.00177 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.96

Safety of [ 75680-92-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 75680-92-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 75680-92-1 ]
  • Downstream synthetic route of [ 75680-92-1 ]

[ 75680-92-1 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 75680-92-1 ]
  • [ 66346-83-6 ]
Reference: [1] Nippon Kagaku Zasshi, 1957, vol. 78, p. 577,579, 580[2] Chem.Abstr., 1959, p. 5275
[3] Bulletin de la Societe Chimique de France, 1959, p. 1793,1796
  • 2
  • [ 75680-92-1 ]
  • [ 5096-73-1 ]
YieldReaction ConditionsOperation in experiment
91% With lithium hydroxide In tetrahydrofuran; water at 20℃; for 0.75 h; Procedure for synthesis of 6-chloropyridazine-3-carboxylic acid (Step-1) To a mixture of ethyl 6-chloropyridazine-3-carboxylate (commercially available) (1.00 g, 5.36 mmol) in THF (10 mL) was added LiOH (0.655 g, 26.8 mmol, 5 equiv.) in water (10 mL). The resulting reaction mixture was stirred at ambient temperature for 45mins. The reaction mixture was poured into 2M hydrochloric acid and extracted with DCM. The organics were combined and evaporated to give product as a white solid (770 mg, 91 percent). LC-MS: (positive ES MH+ 159/161 ).
Reference: [1] Patent: WO2015/67701, 2015, A1, . Location in patent: Page/Page column 44
  • 3
  • [ 63001-31-0 ]
  • [ 75680-92-1 ]
YieldReaction ConditionsOperation in experiment
68.7% at 100℃; for 2 h; A solution of 15 (1.17 g, 6.96 mmol) in phosphorus oxychloride (12 mL) was heated at 100 °C for 2 h. After cooling, the solution was concentrated in vacuo to 3 mL, and the residue was carefully poured into ice water, slowly neutralized with 10percent NaOH aqueous solution in ice bath, and then extracted with ethyl acetate. The organic layer was washed with saturated NaCl aqueous solution, dried over anhydrous MgSO4, and evaporated in vacuo. The residue was purified by flash chromatography on silica gel (200-300 mesh, hexane: ethyl acetate = 3:1) to obtain the compound 16 as a white solid (892 mg, yield 68.7percent). Mp: 145.6-146.7 °C (Ref. melting point 154-155 °C [56]).
55% at 100℃; for 2 h; Inert atmosphere The compound 33a obtained in the previous step was placed in a 25 mL one-necked round bottom flask,Nitrogen substitution,Add 12mL of phosphorus oxychloride,Heated to 100 ° C reaction 2h,The reaction was stopped,Cooling and standing,The reaction solution was slowly poured into ice water under magnetic stirring,And then with 10percent sodium hydroxide solution adjusted PH value of about 7,Precipitation solid, filtration, silica gel column chromatography separation and purification,Obtained as a white solid 812.4 mg.Yield: 55percent;
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 137, p. 598 - 611
[2] Patent: CN106187910, 2016, A, . Location in patent: Paragraph 0242; 0243
[3] Nippon Kagaku Zasshi, 1957, vol. 78, p. 577,579, 580[4] Chem.Abstr., 1959, p. 5275
[5] Bulletin de la Societe Chimique de France, 1959, p. 1793,1796
  • 4
  • [ 1211587-01-7 ]
  • [ 75680-92-1 ]
YieldReaction ConditionsOperation in experiment
52% With 2-(Dimethylamino)pyridine In ethanol The carboxylic acid (243 mg, 1.53 mmol) was dissolved in ~15 mL of ethanol and treated with 24 mg (0.2 mmol) of dimethylaminopyridine (DMAP) followed by 324 mg (1.69
mmol) 1-(3-dimethylaminopropyl-3-ethylcarbodiimide hydrochloride (EDCl).
The reaction was stirred at ambient temperature for 4 hours and then worked up by the procedure described in Example 166A.
The crude product was purified by flash chromatography on silica gel to give 150 mg (52percent) of the title compound as a white crystalline solid. 1 H NMR (CDCl3, 300 MHz) δ 1.45 (t, 3H), 4.55 (q, 2H), 7.65 (d, 1H), 8.15 (d, 1H). MS (DCl/NH3) m/e 187/189 (M+H)+, 204/206 (M+H+NH3)+.
Reference: [1] Patent: US5250548, 1993, A,
  • 5
  • [ 63001-31-0 ]
  • [ 37972-69-3 ]
  • [ 75680-92-1 ]
Reference: [1] Patent: US5340808, 1994, A,
  • 6
  • [ 63001-31-0 ]
  • [ 75680-92-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1994, vol. 42, # 2, p. 371 - 372
[2] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 16, p. 1867 - 1870
  • 7
  • [ 328-50-7 ]
  • [ 75680-92-1 ]
Reference: [1] Patent: CN106187910, 2016, A,
[2] European Journal of Medicinal Chemistry, 2017, vol. 137, p. 598 - 611
  • 8
  • [ 27372-38-9 ]
  • [ 75680-92-1 ]
Reference: [1] Patent: CN106187910, 2016, A,
[2] European Journal of Medicinal Chemistry, 2017, vol. 137, p. 598 - 611
  • 9
  • [ 37972-69-3 ]
  • [ 75680-92-1 ]
Reference: [1] Patent: CN106187910, 2016, A,
[2] European Journal of Medicinal Chemistry, 2017, vol. 137, p. 598 - 611
  • 10
  • [ 37972-69-3 ]
  • [ 75680-92-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1994, vol. 42, # 2, p. 371 - 372
  • 11
  • [ 13327-27-0 ]
  • [ 75680-92-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1994, vol. 42, # 2, p. 371 - 372
  • 12
  • [ 952591-28-5 ]
  • [ 75680-92-1 ]
Reference: [1] Patent: WO2009/25751, 2009, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 75680-92-1 ]

Chlorides

Chemical Structure| 65202-50-8

[ 65202-50-8 ]

Methyl 6-chloropyridazine-3-carboxylate

Similarity: 0.96

Chemical Structure| 5096-73-1

[ 5096-73-1 ]

6-Chloropyridazine-3-carboxylic acid

Similarity: 0.89

Chemical Structure| 372118-01-9

[ 372118-01-9 ]

Methyl 4,6-dichloropyridazine-3-carboxylate

Similarity: 0.78

Chemical Structure| 1121-79-5

[ 1121-79-5 ]

3-Chloro-6-methylpyridazine

Similarity: 0.64

Chemical Structure| 66346-83-6

[ 66346-83-6 ]

6-Chloropyridazine-3-carboxamide

Similarity: 0.64

Esters

Chemical Structure| 65202-50-8

[ 65202-50-8 ]

Methyl 6-chloropyridazine-3-carboxylate

Similarity: 0.96

Chemical Structure| 372118-01-9

[ 372118-01-9 ]

Methyl 4,6-dichloropyridazine-3-carboxylate

Similarity: 0.78

Chemical Structure| 1352925-63-3

[ 1352925-63-3 ]

Ethyl 4,6-dihydroxypyridazine-3-carboxylate

Similarity: 0.62

Chemical Structure| 1093860-48-0

[ 1093860-48-0 ]

Methyl 6-chloropyridazine-4-carboxylate

Similarity: 0.60

Chemical Structure| 2199-43-1

[ 2199-43-1 ]

Ethyl 1H-pyrrole-2-carboxylate

Similarity: 0.59

Related Parent Nucleus of
[ 75680-92-1 ]

Pyridazines

Chemical Structure| 65202-50-8

[ 65202-50-8 ]

Methyl 6-chloropyridazine-3-carboxylate

Similarity: 0.96

Chemical Structure| 5096-73-1

[ 5096-73-1 ]

6-Chloropyridazine-3-carboxylic acid

Similarity: 0.89

Chemical Structure| 372118-01-9

[ 372118-01-9 ]

Methyl 4,6-dichloropyridazine-3-carboxylate

Similarity: 0.78

Chemical Structure| 2164-61-6

[ 2164-61-6 ]

Pyridazine-3-carboxylic acid

Similarity: 0.70

Chemical Structure| 1121-79-5

[ 1121-79-5 ]

3-Chloro-6-methylpyridazine

Similarity: 0.64